Dr. Rubin has 30+ years of industry experience with extensive experience in discovery research. He has developed multiple products for pulmonary, immunology, ophthalmology, neurology, oncology, and orphan indications. Dr. Rubin has taken multiple compounds from concept to approval and has been directly involved in building R and D organizations, as well as new commercial organizations. He also has extensive experience in communication with Wall Street and has been personally involved in raising more than one billion dollars in new capital.
Dr. Rubin has experience with all phases of drug development including target selection, in vitro and in vivo analysis in support of lead selection, translational research, surrogate marker development, all IND enabling activity including toxicology and manufacturing, design and analysis of first-in-human trials.